New prostate cancer biomarkers move closer to clinical use
Friday, June 17, 2011 - 08:30
in Health & Medicine
Conway Fellow, Professor William Watson and Professor John Fitzpatrick, UCD School of Medicine and Medical Science and Mater Misericordiae University Hospital recently received a translational research award for the validation of a panel of serum biomarkers to inform surgical intervention for prostate cancer.